AbSci nabs $10.4 mln Series D

Vancouver, Washington-based AbSci, a protein printing company, has closed $10.4 million in Series D financing.

13 January 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles